Compare Hinge Health Inc. Class A Common Stock (HNGE) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs HP Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while HP Inc trades at $30.42 (market cap $27.47B). The key difference: HP Inc is far larger — about 3.2× Hinge Health Inc. Class A Common Stock's market cap, and HP Inc pays a 3.94% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and HP Inc for 70 Days on average.
| HNGE | HPQ | |
|---|---|---|
Market Cap | $8.47B | $27.47B |
Volume | 1,624,526 | 11,226,290 |
Sector | Health | Technology |
52-Week High | $105.14 | $35.48 |
52-Week Low | $31.17 | $18.20 |
Typical Hold Time | 0 Days | 70 Days |
Enterprise Value | $8.09B | $33.64B |
Dividend Yield | — | 3.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
HPQ trades at $30.63, up 2.54% today, with a bearish technical signal but strong earnings beats in recent quarters. The company reported $55.3B revenue in 2025 with a net income margin of 4.14%, supported by a low P/E of 11.69. Recent news highlights product launches and AI integration in PCs, though the stock faces headwinds from a forecasted PC market decline in 2027.
The outlook is mixed: valuation metrics appear attractive, and dividend sustainability is supported by cash flow, but risks from PC market softness and negative shareholder equity warrant caution. Analyst consensus is neutral with a $25.75 price target, suggesting limited upside from current levels amid industry challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
